133 related articles for article (PubMed ID: 31027678)
21. Breast Tumor Prognostic Characteristics and Biennial vs Annual Mammography, Age, and Menopausal Status.
Miglioretti DL; Zhu W; Kerlikowske K; Sprague BL; Onega T; Buist DS; Henderson LM; Smith RA;
JAMA Oncol; 2015 Nov; 1(8):1069-77. PubMed ID: 26501844
[TBL] [Abstract][Full Text] [Related]
22. Menopausal hormone therapy in relation to breast cancer characteristics and prognosis: a cohort study.
Rosenberg LU; Granath F; Dickman PW; Einarsdóttir K; Wedrén S; Persson I; Hall P
Breast Cancer Res; 2008; 10(5):R78. PubMed ID: 18803850
[TBL] [Abstract][Full Text] [Related]
23. The influence of hormone therapies on type I and II endometrial cancer: A nationwide cohort study.
Mørch LS; Kjaer SK; Keiding N; Løkkegaard E; Lidegaard Ø
Int J Cancer; 2016 Mar; 138(6):1506-15. PubMed ID: 26421912
[TBL] [Abstract][Full Text] [Related]
24. Hormone therapy for preventing cardiovascular disease in post-menopausal women.
Main C; Knight B; Moxham T; Gabriel Sanchez R; Sanchez Gomez LM; Roqué i Figuls M; Bonfill Cosp X
Cochrane Database Syst Rev; 2013 Apr; (4):CD002229. PubMed ID: 23633307
[TBL] [Abstract][Full Text] [Related]
25. Endometrial carcinoma risks among menopausal estrogen plus progestin and unopposed estrogen users in a cohort of postmenopausal women.
Lacey JV; Brinton LA; Lubin JH; Sherman ME; Schatzkin A; Schairer C
Cancer Epidemiol Biomarkers Prev; 2005 Jul; 14(7):1724-31. PubMed ID: 16030108
[TBL] [Abstract][Full Text] [Related]
26. A multicentric study regarding the use of hormone therapy during female mid-age (REDLINC VI).
Blümel JE; Chedraui P; Barón G; Benítez Z; Flores D; Espinoza MT; Gomez G; González E; Hernández L; Lima S; Martino M; Montaño A; Monterrosa A; Mostajo D; Ojeda E; Onatra W; Robles C; Saavedra J; Sánchez H; Tserotas K; Vallejo MS; Vallejo C;
Climacteric; 2014 Aug; 17(4):433-41. PubMed ID: 24443950
[TBL] [Abstract][Full Text] [Related]
27. Hormone replacement therapy and breast cancer mortality in Swedish women: results after adjustment for 'healthy drug-user' effect.
Yuen J; Persson I; Bergkvist L; Hoover R; Schairer C; Adami HO
Cancer Causes Control; 1993 Jul; 4(4):369-74. PubMed ID: 8394149
[TBL] [Abstract][Full Text] [Related]
28. Cardiovascular and cancer morbidity and mortality and sudden cardiac death in postmenopausal women on oestrogen replacement therapy (ERT).
Sourander L; Rajala T; Räihä I; Mäkinen J; Erkkola R; Helenius H
Lancet; 1998 Dec 19-26; 352(9145):1965-9. PubMed ID: 9872245
[TBL] [Abstract][Full Text] [Related]
29. Postmenopausal hormone replacement therapy: scientific review.
Nelson HD; Humphrey LL; Nygren P; Teutsch SM; Allan JD
JAMA; 2002 Aug; 288(7):872-81. PubMed ID: 12186605
[TBL] [Abstract][Full Text] [Related]
30. Knowledge of reproductive physiology and hormone therapy in 53- to 54-year-old Swedish women: a population-based study.
Lindh-Astrand L; Brynhildsen J; Hoffmann M; Kjellgren KI; Hammar M
Menopause; 2007; 14(6):1039-46. PubMed ID: 17519805
[TBL] [Abstract][Full Text] [Related]
31. Hormone therapy: the European women's perspective.
Strothmann A; Schneider HP
Climacteric; 2003 Dec; 6(4):337-46. PubMed ID: 15006255
[TBL] [Abstract][Full Text] [Related]
32. Association between tubal ligation and endometrial cancer risk: A Swedish population-based cohort study.
Falconer H; Yin L; Altman D
Int J Cancer; 2018 Jul; 143(1):16-21. PubMed ID: 29388208
[TBL] [Abstract][Full Text] [Related]
33. Initiating therapy with antidepressants after discontinuation of hormone therapy.
Citarella A; Andersen M; Sundström A; Bardage C; Hultman CM; Kieler H
Menopause; 2013 Feb; 20(2):146-51. PubMed ID: 22929038
[TBL] [Abstract][Full Text] [Related]
34. Cardiovascular disease in women with breast cancer - a nationwide cohort study.
Jakobsen M; Kolodziejczyk C; Jensen MS; Poulsen PB; Khan H; Kümler T; Andersson M
BMC Cancer; 2021 Sep; 21(1):1040. PubMed ID: 34537007
[TBL] [Abstract][Full Text] [Related]
35. Lifetime weight history and endometrial cancer risk by type of menopausal hormone use in the NIH-AARP diet and health study.
Chang SC; Lacey JV; Brinton LA; Hartge P; Adams K; Mouw T; Carroll L; Hollenbeck A; Schatzkin A; Leitzmann MF
Cancer Epidemiol Biomarkers Prev; 2007 Apr; 16(4):723-30. PubMed ID: 17416763
[TBL] [Abstract][Full Text] [Related]
36. The new Swedish Prescribed Drug Register--opportunities for pharmacoepidemiological research and experience from the first six months.
Wettermark B; Hammar N; Fored CM; Leimanis A; Otterblad Olausson P; Bergman U; Persson I; Sundström A; Westerholm B; Rosén M
Pharmacoepidemiol Drug Saf; 2007 Jul; 16(7):726-35. PubMed ID: 16897791
[TBL] [Abstract][Full Text] [Related]
37. Estrogen therapy and risk of breast cancer in postmenopausal women: a case-control study and results of a multivariate analysis.
Lumachi F; Frigo AC; Basso U; Tombolan V; Ermani M
Menopause; 2010; 17(3):524-8. PubMed ID: 20130492
[TBL] [Abstract][Full Text] [Related]
38. Association between menopausal hormone therapy use and mortality risk: a Swedish population-based matched cohort study.
Simin J; Khodir H; Fornes R; Tamimi RM; Brusselaers N
Acta Oncol; 2022 May; 61(5):632-640. PubMed ID: 35129052
[TBL] [Abstract][Full Text] [Related]
39. Risk of endometrial and breast cancer in patients with diabetes mellitus.
Weiderpass E; Gridley G; Persson I; Nyrén O; Ekbom A; Adami HO
Int J Cancer; 1997 May; 71(3):360-3. PubMed ID: 9139868
[TBL] [Abstract][Full Text] [Related]
40. Endometrial cancer and menopausal hormone therapy in the National Institutes of Health-AARP Diet and Health Study cohort.
Lacey JV; Leitzmann MF; Chang SC; Mouw T; Hollenbeck AR; Schatzkin A; Brinton LA
Cancer; 2007 Apr; 109(7):1303-11. PubMed ID: 17315161
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
